Direct-to-patient (DTP) models are being utilized more and more in recent years. While this provides pharma companies with new opportunities to reach patient populations, it also creates new complications that they need to find solutions for. Scott Snyder, chief digital officer at EVERSANA, spoke with Pharmaceutical Executive about these types of models and the solutions that companies are employing.
“Direct-to-patient models will continue to evolve and become more sophisticated with technologies like AI to further personalize patient experiences and improve outcomes.” – Scott Snyder, Chief Digital Officer
Read the full article on Pharmaceutical Executive here: Trends Shaping Direct to Patient in Pharma: Q&A with Scott Snyder
Connect With An Expert!
Author
Scott serves as EVERSANA’s Chief Digital Officer, driving digital transformation for employees, clients, and the patients we serve. He brings more than 30 years of experience in emerging technologies and digital transformation across both…